| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $202,568,387 ) (Continued on the next page) |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01DK138986 | Macrophage miR-130b/301b and beige adipogenesis | 000 | 1 | NIH | 4/1/2024 | $451,245 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R35GM153265 | Decoding mitogen-activated protein kinase signaling networks | 000 | 1 | NIH | 4/25/2024 | $326,625 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01AI182086 | Chemoproteomic discovery and functional characterization of infection-induced oxidation sites | 000 | 1 | NIH | 1/5/2024 | $637,139 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01HG012969 | Multimodal Analysis of the Genome Architecture Using Expansion Microscopy | 000 | 1 | NIH | 3/1/2024 | $645,285 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | K99DC021743 | A new dimension to the olfactory system: long non-coding (lnc)RNAs and a lncRNA-encoded micropeptide | 000 | 1 | NIH | 2/5/2024 | $122,986 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01HL167071 | Altered RNA fates due to an MDS driver mutation in SF3B1 | 000 | 1 | NIH | 12/22/2023 | $557,777 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R35GM153474 | The genetic and non-genetic responses of chromatin to force | 000 | 1 | NIH | 3/15/2024 | $415,289 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01AG071587 | Microglia-specific proteomic mechanisms and biomarkers of neuroinflammation in Alzheimer?s disease | 000 | 3 | NIH | 4/24/2024 | $764,472 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01AG068191 | Novel integrative imaging genetics analysis for Alzheimer's disease riskand progression | 000 | 2 | NIH | 4/24/2024 | $616,832 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01NS132868 | Molecular mechanisms of somatosensory adaptation to prolonged hypothermia | 000 | 1 | NIH | 12/22/2023 | $556,452 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R21CA280372 | Identification of metabolic niches in African Americans with colorectal cancer | 000 | 1 | NIH | 12/15/2023 | $195,766 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01NS136442 | A flexible, low power, multi-channel, real-time BCI for seizure monitoring and Modulation | 000 | 1 | NIH | 3/1/2024 | $638,036 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F31AR082696 | Leveraging mosaic genodermatoses to discover genetic and molecular mechanisms of comedogenesis | 000 | 1 | NIH | 3/8/2024 | $32,678 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F31AR082696 | Leveraging mosaic genodermatoses to discover genetic and molecular mechanisms of comedogenesis | 001 | 1 | NIH | 3/8/2024 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01DK135645 | Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetes | 000 | 1 | NIH | 1/18/2024 | $728,612 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F30CA287869 | Next-generation diagnostic approaches for HER2-low breast cancer and trastuzumab deruxtecan therapy | 001 | 1 | NIH | 2/28/2024 | $0 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F30CA287869 | Next-generation diagnostic approaches for HER2-low breast cancer and trastuzumab deruxtecan therapy | 000 | 1 | NIH | 2/28/2024 | $32,678 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F30AI181493 | The role of a Coxiella burnetii effector protein that inhibits RIG-I signaling | 001 | 1 | NIH | 11/20/2023 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01HL171984 | Readily Available Biological Conduits to Treat Single Ventricle Defects | 000 | 1 | NIH | 11/21/2023 | $514,699 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F30AI181493 | The role of a Coxiella burnetii effector protein that inhibits RIG-I signaling | 000 | 1 | NIH | 11/20/2023 | $32,642 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | S10OD036350 | Cell sorting flow cytometer for BSL3 research | 000 | 1 | NIH | 4/23/2024 | $351,321 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R21HL173512 | Local cellular communication networks in COPD endotypes | 000 | 1 | NIH | 4/5/2024 | $125,625 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R00MH129565 | Dissecting the functional organization of local hippocampal circuits underlying spatial representations | 000 | 2 | NIH | 3/8/2024 | $248,999 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01DK134624 | Oral digoxin for the treatment of NASH | 000 | 1 | NIH | 3/8/2024 | $609,266 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R21CA286364 | CAR mast cell for solid tumor | 000 | 1 | NIH | 2/2/2024 | $241,713 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | K99CA282989 | Reprogramming T cell function with multiplexed genome engineering to develop next-generation immunotherapy | 000 | 1 | NIH | 3/8/2024 | $142,502 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R21MH134183 | Noradrenergic circuits in heights avoidance: an ethological, translatable threat behavior | 000 | 1 | NIH | 3/5/2024 | $220,500 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | K08DK133687 | Epithelial-immune interactions in neonates with Spontaneous Intestinal Perforation | 000 | 1 | NIH | 1/26/2024 | $167,327 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01CA278212 | Cue-101 and TCR-T cell Combinatorial Strategy for HPV+ Head and Neck Cancers | 000 | 1 | NIH | 2/16/2024 | $691,530 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01NS125482 | Identifying and targeting the neural basis of depression in Parkinson's disease | 000 | 1 | NIH | 1/23/2024 | $625,896 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R21AI180187 | Targeting complement-induced IL-15 trans-presentation by human endothelial cells | 000 | 1 | NIH | 11/29/2023 | $226,125 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R21EY036254 | Neuromodulatory regulation of cortical functional connectivity | 000 | 1 | NIH | 4/11/2024 | $250,913 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F31AI183702 | Elucidating the Cellular and Molecular Mechanisms of IgE Catabolism | 001 | 1 | NIH | 3/21/2024 | $0 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | F31AI183702 | Elucidating the Cellular and Molecular Mechanisms of IgE Catabolism | 000 | 1 | NIH | 3/21/2024 | $47,694 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01AI181379 | Immune signatures of vaccine responses in children with sickle cell disease | 000 | 1 | NIH | 11/27/2023 | $568,910 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31GM149144 | Disease consequences and regulation of autophagy-independent ATG3 activity | 002 | 1 | NIH | 1/10/2024 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31GM149144 | Disease consequences and regulation of autophagy-independent ATG3 activity | 001 | 1 | NIH | 1/10/2024 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31GM149144 | Disease consequences and regulation of autophagy-independent ATG3 activity | 000 | 1 | NIH | 1/10/2024 | $47,694 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31DK137452 | Fate Specification of CFTR High Expresser Cells in the Intestine | 000 | 1 | NIH | 2/1/2024 | $32,642 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R21AI180408 | Regulation of hematopoiesis and trained immunity by innate lymphocytes | 000 | 1 | NIH | 11/28/2023 | $226,125 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R37CA285640 | Uncovering Oncogenotype-specific Vulnerabilities in Lung cancer | 000 | 1 | NIH | 4/10/2024 | $480,137 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R35GM153482 | Mechanisms of autophagosome biogenesis | 000 | 1 | NIH | 3/29/2024 | $396,781 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | R01HG013371 | A paradigm for comprehensive genetic association studies of complex disease using pangenomic methods and local ancestry inference | 000 | 1 | NIH | 1/10/2024 | $660,491 |
| 2024 | 2024 | YALE UNIV | 150 MUNSON ST | NEW HAVEN | CT | 06511-3572 | NEW HAVEN | USA | R01NS132860 | In-depth characterization of B-cell dysfunction in chronic inflammatory demyelinating polyneuropathy | 000 | 1 | NIH | 3/29/2024 | $414,898 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31NS135909 | Targeted degradation of NaV1.8 as a therapeutic strategy for pain | 001 | 1 | NIH | 12/19/2023 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31NS135909 | Targeted degradation of NaV1.8 as a therapeutic strategy for pain | 000 | 1 | NIH | 12/19/2023 | $32,642 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31NS130942 | Genetic and epigenetic mechanisms of glioblastoma invasion and their therapeutic implication | 000 | 1 | NIH | 11/30/2023 | $47,694 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31NS130957 | Investigating the mechanism and role of the steady-state CXCR3-CXCL10 gut-microbiota-brain T cell axis | 001 | 1 | NIH | 12/19/2023 | $0 |
| 2024 | 2024 | YALE UNIVERSITY | 105 WALL ST | NEW HAVEN | CT | 06511-8917 | NEW HAVEN | USA | F31EY035937 | Impact of CDKL5 deficiency on thalamocortical dynamics | 001 | 1 | NIH | 11/30/2023 | $0 |
|